Safety Study of CPX-351 in Children With Relapsed Leukemia or Lymphoma. - Trial 2017-003434-87
Access comprehensive clinical trial information for 2017-003434-87 through Pure Global AI's free database. This phase not specified trial is sponsored by Cincinnati Children's Hospital Medical Center and is currently status unknown. The study focuses on Acute Myeloid Leukemia.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Cincinnati Children's Hospital Medical Center
Jazz Pharmaceuticals
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
- Patients with Acute Promyelocytic Leukemia (APML), Down Syndrome, Fanconi Anemia, ALL and CNS leukemia (CNS status 3).
ICD-10 Classifications
Data Source
EU Clinical Trials Register
2017-003434-87
Non-Device Trial